Introduction
The tetrahydroisoquinoline ring structure is present in a large number of natural and biologically active products. Derivatives with a substituent in the 1-position are particularly common and are typically prepared by Pictet-Spengler or BischlerNapieralksi reactions. 1 Other methods include addition to iminium ions or reduction of isoquinoline rings. 2 An alternative approach to such compounds makes use of the ability to deprotonate at the 1-position of the tetrahydroisoquinoline ring. This method has potential to provide access to a large range of differently substituted derivatives. Various Nsubstituents on the tetrahydroisoquinoline can be used to aid the metallation. 3 We have reported that an efficient and relatively mild method is to use the N-Boc derivative with deprotonation by using n-BuLi. 4, 5 However we have so far
reported only a few examples with the parent compound NBoc-tetrahydroisoquinoline 1 and with the 6,7-dimethoxy derivative 2 ( Fig. 1) . 4 Here we demonstrate that the chemistry is amenable to other substituted tetrahydroisoquinolines and to a variety of different electrophiles, leading to its application to the syntheses of the alkaloids (±)-crispine A and (±)-dysoxyline.
In our earlier work we showed that the Boc group in N-Boctetrahydroisoquinoline rotates slowly at -78 °C. 4 As the lithiation at the 1-position is directed by complexation of the base (n-butyllithium) with the carbonyl of the Boc group, 6 better yields can be obtained at -50 °C since the Boc rotation is faster. We wanted to test whether the same phenomenon also occurs with other derivatives and whether the lithiationsubstitution chemistry is amenable to different substituted tetrahydroisoquinolines. The lithiations of a selection of N-Boctetrahydroisoquinoline compounds (2) (3) (4) (5) and applications of this chemistry to the preparation of some natural products are described in this article. 
Results and discussion
We selected to prepare the tetrahydroisoquinolines 2-5 ( Fig.  1 ). These compounds provide a range of electron-donating (alkoxy) and electron-withdrawing (chloro and trifluoromethyl) groups on the tetrahydroisoquinolines used for the lithiation chemistry. For syntheses of compounds 2-5, see the Supplementary Information. The lithiation of tetrahydroisoquinoline 3 was monitored by in situ ReactIR spectroscopy. With 1.2 equivalents of n-BuLi in THF at -78 °C the lithiation was slow. However, by conducting the reaction at -50 °C a rapid lithiation took place ( Figure 2 ). This result indicates that the rotation of the Boc group is slow at -78 °C, but fast at -50 °C, in line with previous work. 4, 7 The n-BuLi coordinates to the carbonyl oxygen atom of .
Scheme 1
Lithiation-substitution of the tetrahydroisoquinoline 3.
By using the optimised lithiation conditions (THF, -50 °C, 4 min), followed by electrophilic quench and purification by column chromatography, the substituted products 6a-c were obtained with reasonable to good yields (Scheme 1). Lithiation occurs only in the benzylic position, as judged by 1 H NMR spectroscopy. We did not observe any other substitution products.
To expand the range of substrates beyond the parent or electron-rich tetrahydroisoquinolines (compounds 1-3), we prepared the tetrahydroisoquinolines 4 and 5 (see the Supplementary Information). We found that these compounds behaved in a similar way and lithiation could be achieved at -50 °C over the course of only a few minutes. Some examples of the substitution products that were obtained in this chemistry are shown in Schemes 2 and 3. The chemistry was successful for a variety of electrophiles including alkyl and allyl bromides, and trialkyltin or silyl chlorides. After column chromatography reasonable to good yields of the 1-substituted products 7a-d and 8a-c were obtained. The lithiation-substitution was selective for the 1-position, indicating that the Boc group is a better directing group for lithiation than CF 3 or chlorine.
As mentioned above, in the lithiation step the n-BuLi coordinates to the carbonyl oxygen atom, 6 so the rate of lithiation will depend on the rate of rotation of the Boc group. We had previously determined an approximate value for the barrier to rotation, ∆G ‡ ≈ 60.8 kJmol -1 at 5.5 °C of the parent compound 1. 4 We therefore decided to determine the kinetics the Boc group in both compounds 4 and 1. From this we can determine, for rotation of the Boc group in 4, the half-life t 1/2 ≈ 2 min at -50 °C. Therefore the lithiation requires only a few minutes at this temperature for complete reaction. By using 1.2 equivalents of the electrophile 1,3-dibromopropane, the 1-substituted product 7d was formed without any appreciable formation of the product from double electrophilic substitution. The product 7d was treated with trifluoroacetic acid (TFA) (Scheme 4). This resulted in the removal of the Boc group and concomitant cyclization to give the product 9 in high yield.
Please do not adjust margins Please do not adjust margins Variable temperature NMR spectroscopy of tetrahydroisoquinoline 4 in D8-THF showing selected spectra only the region from 5.00-3.50 ppm.
Scheme 4
Removal of Boc group from the tetrahydroisoquinoline 7d.
We were interested to test dibromoalkane electrophiles further and selected to use the tetrahydroisoquinoline substrate 2 for this work. Lithiation of compound 2 with n-BuLi in THF at -50 °C for 4 min followed by addition of more than one equivalent of 1,3-dibromopropane or 1,4-dibromobutane gave the expected 1-substituted products 10 and 11 (Scheme 5) . By using 0.5 equivalents of 1,3-dibromopropane we were able to prepare the 1,1'-disubstituted product 14 as a separable mixture of diastereoisomers. Related bistetrahydroisoquinolinium salts have recently been found to be high affinity ligands for SK channels. 
Scheme 5
Use of dibromoalkane electrophiles and synthesis of (±)-crispine A.
Treatment of the crude product 10 with trifluoroacetic acid gave the natural product (±)-crispine A, 12, in 52% yield over the two steps. This chemistry therefore provides a short and efficient synthesis of this compound (just three steps from commercial 6,7-dimethoxytetrahydroisoquinoline). 9 In the same way as the formation of crispine A, hydrolysis of the Boc group from compound 11 was carried out to provide the homologous product 13 in high yield (Scheme 5).
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To expand the range of electrophiles that have been shown to be successful in these alkylation reactions, we treated the tetrahydroisoquinoline 2 with n-BuLi in THF at -50 °C for 4 min followed by addition of propargyl bromide or 4-methoxybenzyl chloride (Scheme 6). The products 15 and 16 were isolated with good yields.
We have demonstrated that the Boc group can be removed from several of these products (7d, 10, 11) by using TFA. Other transformations of the substituted products are possible. For example, treating the product 15 with benzyl azide and a copper catalyst gave the expected triazole 17 (Scheme 7).
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Reduction of the Boc group in the tetrahydroisoquinoline 6b with LiAlH 4 gave the N-methyl derivative 18 (Scheme 8). Finally, we prepared the natural product (±)-dysoxyline using this chemistry. 12 The tetrahydroisoquinoline 2 was deprotonated under the standard conditions and then treated with the bromide 19 (Scheme 9). We were pleased that this gave a good yield of the 1-substituted product 20 despite the potential for β-elimination. Reduction of this product with LiAlH 4 gave (±)-dysoxyline 21. Hence this chemistry allows an efficient way to prepare simple tetrahydroisoquinoline alkaloids.
Scheme 9
Synthesis of (±)-dysoxyline.
Conclusions
We have found that the lithiation of N-Boctetrahydroisoquinolines can be extended to a selection of different substituted derivatives by using the conditions found previously for the parent compound (1) and this requires only a few minutes at -50 °C with n-butyllithium. The intermediate organolithium can be trapped with a wide selection of different electrophiles to give good yields of a variety of 1-substituted tetrahydroisoquinoline products. The chemistry was applied to the short syntheses of the alkaloids crispine A and dysoxyline. n-BuLi (0.17 mL, 0.43 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 3 (100 mg, 0.36 mmol) in THF (1.5 mL) at -50 °C. After 4 min, iodomethane (0.08 mL, 1.26 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrol- EtOAc (92:8) 9 & 154.4, 146.1, 146.0, 127.3, 127.1, 108.4, 106.7, 100.7, 79.6, 50.5 & 49.8, 38.0 & 36.6, 29.6, 29.0 & 28.0, 22.0 
tert-Butyl

5-Benzyl-7,8-dihydro-[1,3]dioxolo[4,5-g]isoquinoline-6(5H)-carboxylate 6b
n-BuLi (0.17 mL, 0.43 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 3 (100 mg, 0.36 mmol) in THF (1.5 mL) at -50 °C. After 4 min, benzyl bromide (0.15 mL, 1.26 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrolEtOAc (93:7), to give the carbamate 6b (87 mg, 66%) as an oil; R ƒ 0.41 5 & 154.3, 146.3 & 146.1, 145.8 & 145.7, 138.5 & 138.1, 130.1 & 130.0, 129.7 & 129.6, 129.0 & 128.8, 128.3, 128.1, 127.8 & 127.7, 126.4 & 126.2, 108.6 & 108.2, 107.6 & 107.2, 100.8 & 100.7, 79.6 & 79.4, 56.8 & 55.7, 43.0 & 42.7, 39.3 & 37.0, 29.7 & 28.6, 28.5 & 28.4 
tert-Butyl 7,8-Dihydro-5-(trimethylsilyl)-[1,3]dioxolo[4,5-g]isoquinoline-6(5H)-carboxylate 6c
n-BuLi (0.17 mL, 0.43 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 3 (100 mg, 0.36 mmol) in THF (1.5 mL) at -50 °C. After 4 min, Me 3 SiCl (0.16 mL, 1.2 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrol-EtOAc (92:8) 4, 145.9 & 144.8, 145.1 & 144.9, 130.3 & 129.7, 125.7 & 125.6, 108.9 & 108.6, 105.4 & 105.1, 100.7 & 100.6, 79.7 & 79.2, 49.9 & 49.0, 41.0 & 39.8, 28.9 & 28.55, 28.5, -1.4 & -1.6 tert-Butyl 1-Butyl-5-(trifluoromethyl)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate 7a n-BuLi (0.19 mL, 0.49 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 4 (100 mg, 0.33 mmol) in THF (1.5 mL) at -50 °C. After 4 min, n-butyl bromide (0.12 mL, 1.16 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrolEtOAc (98:2), to give the carbamate 7a (70 mg, 60%) as an oil; R ƒ 0.36 7, 54.9 & 54.1, 37.7 & 36.9, 36.5 & 35.9, 29.7 & 28.7, 28.4, 25.2 & 25.1, 22.5, 14. tert-Butyl 5-(Trifluoromethyl)-3,4-dihydro-1-(3-phenoxypropyl)isoquinoline-2(1H)-carboxylate 7c n-BuLi (0.19 mL, 0.49 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 4 (100 mg, 0.33 mmol) in THF (1.5 mL) at -50 °C. After 4 min, Br(CH 2 ) 3 OPh (0.17 mL, 1.16 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrolEtOAc (99:1), to give the carbamate 7c (90 mg, 64%) as an oil; R ƒ 0.22 2 & 130.9, 129.4, 128.6 (q, J 31), 125.8, 124.3, 121.0 (CF 3 , q, J 274), 120.7 & 120.6, 114.5, 80.2 & 79.9, 67.2, 54.6 & 53.7, 37.6 & 36.0, 33.5 & 33.1, 29.7 & 28.4, 26.2, 25.2 & 25.0 1-(3-Bromopropyl)-5-(trifluoromethyl)-1,2,3 ,4-tetrahydroisoquinoline-2-carboxylate 7d n-BuLi (0.31 mL, 0.78 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 4 (200 mg, 0.66 mmol) in THF (3 mL) at -50 °C. After 4 min, Br(CH 2 ) 3 Br (0.08 mL, 0.79 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrolEtOAc (99:1), to give the carbamate 7d (180 mg, 68%) as an oil; R ƒ 0. 
tert-Butyl
tert-Butyl 1-Allyl-7-chloro-3,4-dihydroisoquinoline-2(1H)-carboxylate 8a
n-BuLi (0.17 mL, 0.44 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 5 (100 mg, 0.37 mmol) in THF (1.5 mL) at -50 °C. After 4 min, allyl bromide (0.13 mL, 1.3 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrolEtOAc (98:2), to give the carbamate 8a (100 mg, 91%) as plates m.p. 
tert-Butyl 7-Chloro-3,4-dihydro-1-(trimethylsilyl)isoquinoline-2(1H)-carboxylate 8b
n-BuLi (0.17 mL, 0.44 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 5 (100 mg, 0.37 mmol) in THF (1.5 mL) at -50 °C. After 4 min, Me 3 SiCl (0.13 mL, 1.0 mmol) was added.
The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. 
tert-Butyl 1-(Tributylstannyl)-7-chloro-3,4-dihydroisoquinoline-2(1H)-carboxylate 8c
n-BuLi (0.17 mL, 0.44 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 5 (100 mg, 0.37 mmol) in THF (1.5 mL) at -50 °C. After 4 min, n-Bu 3 SnCl (0.36 mL, 1.3 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrolEtOAc (95:5), to give the carbamate 8b (120 mg, 57%) as an oil; R ƒ 0.6 [petrol-EtOAc (95:5) C=O could not be observed) δ = 131. 8, 130.1 & 129.5, 130.0, 129.9 & 129.8, 123.9 & 123.7, 123.4, 79.4, 49.6 & 49.3, 41.7 & 40.6, 29.0, 28.9 & 28.8, 28.6 & 28.5, 27.4 & 27.3, 13.5, 10.6 & 10.4 53.5, 47.9, 30.6, 25.4, 22.1; HRMS (ES) 8, 147.8, 147.4, 130.2 & 129.8, 126.5 & 126.0, 111.6, 110.2 & 109.9, 79.9 & 79.5, 56.1, 55.9, 54.2 & 53.4, 38.3 & 36.5, 36.2 & 35.7, 33.6, 32.5, 28.4, 27.9, 25.4 & 
m/z (ES) 452 (97%), 450 (100%).
Crispine A 12 n-BuLi (1.63 mL, 4.1 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 2 (1.0 g, 3.4 mmol) in THF (14 mL) at -50 °C. After 4 min, dibromopropane (0.41 mL, 4.1 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated to give the crude product 10. Trifluoroacetic acid (0.37 mL, 4.9 mmol) was added to this crude product 10 in CH 2 Cl 2 (15 mL) and the mixture was stirred at room temperature. After 4 h, the solvent was evaporated and aqueous NaOH (30 mL, 1 M) was added. The mixture was extracted with CH 2 Cl 2 (2 × 20 mL). The combined extracts were dried (MgSO 4 ), evaporated, and purified by column chromatography on silica, eluting with petrol-EtOAc (92:8), to give (±)-crispine A (410 mg, 52%) as an oil; R f 0.18 [petrolEtOAc (80:20) Trifluoroacetic acid (0.1 mL, 1.48 mmol) was added to the tetrahydroisoquinoline 11 (100 mg, 0.24 mmol) in CH 2 Cl 2 (5 mL) and the mixture was stirred at room temperature. After 4 h, the solvent was evaporated and aqueous NaOH (5 mL, 1 M) was added. The mixture was extracted with CH 2 Cl 2 (2 × 5 mL). The combined extracts were dried (MgSO 4 ), evaporated, and purified by column chromatography on silica, eluting with CH 2 Cl 2 -MeOH (97:3), to give the amine 13 (50 mg, 87%) as an oil; R f 0. 9, 147.6, 147.3, 130.6 & 130.1, 126.4 & 126.0, 111.6 & 111.4, 110.3 & 110.0, 79.7 & 79.2, 56.1, 55.9, 54.7 & 53.4, 38.4 & 38.2, 36.9 & 36.2, 28.5, 28.1 & 27.9, 23.5 & m, 4 x CH), m, CH), m, CH), m, CH), m, CH) 8, 147.5, 147.3, 130.5 & 130.0, 126.3 & 125.8, 111.6 & 111.4, 110.3 & 109.9, 79.7 & 79.2, 56.1, 56.0, 54.6 & 53.5, 38.3 & 38.0, 36.9 & 35.5, 28.5, 28.1 & 27.9, 23.6 & 23.2 tert-Butyl 6,7-Dimethoxy-1-(prop-2-yn-1-yl)-1,2,3,4-tetrahydroisoquinoline-2-carboxylate 15 n-BuLi (1.63 mL, 4.08 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 2 (1.0 g, 3.4 mmol) in THF (14 mL) at -50 °C. After 4 min, propargyl bromide (0.36 mL, 4.1 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrolEtOAc (99:1), to give the carbamate 15 (0.88 g, 78%) as an oil; R f 0.1 4, 147.9 & 147.8, 147.3, 127.8 & 127.6, 126.7 & 126.5, 111.4 & 111.2, 110.5 & 110.1, 80.1 & 79.8, 55.9 & 55.8, 53.1 & 52.4, 39.1 & 37.3, 28.4, 28.3 & 28.0, 26.5 & 1, 154.6 & 154.5, 147.6 & 147.5, 146.9 & 146.7, 130.8 & 130.6, 130.7 & 130.5, 128.8 & 128.6, 126.6 & 126.3, 113.7 & 113.5, 111.3 & 111.0, 110.7 & 110.3, 79.5 & 79.4, 56.5, 55.9 & 55.8, 55.7 & 55.6, 55.3 & 55.2, 42.0 & 41.8, 39.3 & 37.2, 28.5 & 28.3 9:1) . After 18 h, the mixture was cooled to room temperature and saturated aqueous NH 4 Cl (30 mL) was added. The precipitate was filtered and washed with water (100 mL). The combined extracts were dried (MgSO 4 ), evaporated, and purified by column chromatography on silica gel, eluting with petrol-EtOAc (60:40), to give the carbamate 17 (570 mg, 83%) as an oil; R f 0.11 8 & 154.4, 147.8, 147.4, 145.2 & 144.8, 135.0 & 134.6, 129.1, 128.8, 128.7 & 128.6, 128.0 & 127.9, 126.2, 121.9, 111.4, 109.9, 79.7 & 79.5, 56.0 & 55.9, 54.4, 54.0, 53.1, 38.3 & 36.4, 32.8, 28.3 & 28.1, 28.0 8, 145.3, 139.9, 130.6, 129.5, 128.1, 127.2, 126.0, 108.4, 107.8, 100.5, 65.2, 46.6, 42.6, 41.6, 25.7 tert-Butyl 1-[2-(2H-1,3-Benzodioxol-5-yl)ethyl]-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carboxylate 20 n-BuLi (1.63 mL, 4.08 mmol, 2.5 M in hexane) was added to tetrahydroisoquinoline 2 (1.0 g, 3.4 mmol) in THF (14 mL) at -50 °C. After 4 min, bromide 19 (900 mg, 1.6 mmol) was added. The mixture was allowed to warm to room temperature over 16 h and MeOH (1 mL) was added. The solvent was evaporated and the residue was purified by column chromatography on silica gel, eluting with petrol-EtOAc (92:8), to give the carbamate 20 (1.08 g, 72%) as an oil; R f 0.12 9, 147.7, 147.4, 145.6, 136.0 & 135.7, 130.1, 129.6, 126.3 & 125.9, 120.9, 111.6, 110.2 & 109.9, 108.7 & 108.1, 100.7, 79.9 & 79.4, 56.0 & 55.9, 54.4 & 53.6, 39.1 & 38.7, 36.9, 32.7, 28.5, 28.1 & 27.9 ; HRMS (ES) Found: MNa + , 464.2032
